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ABSTRACT

Malignant melanoma cancer is the sixth common cancer diagnosed in the United States. Surgery,
chemotherapy and radiation are some of the successful techniques in killing tumor cells.
However, in these techniques, it is not easy to distinguish tumor cells from the healthy once which
inadvertently get exposed to chemical agent/radiation. Therefore it is required to develop an anticancer agent which selectively kills the cancer cells, while still protecting the normal tissues. In
our preliminary work, we have shown that Dextran (1000Da) coated Cerium oxide nanoparticles
(Dex-CNPs) selectively kills the cancer cells (50% killing at a concentration of 150μM) without
inducing toxicity to the normal cells. However, the mechanism involved on how CNPs/Dex-CNPs
attain the selectivity and efficiently kill the tumor cells is still unknown. In this study we have
synthesized Dextran coated ceria nano particles (Dex- CNPs) with different surface oxidation
state ratio (Ce4+/Ce3+). This will provide an in depth understanding of the key chemical and
physical properties of the system that can improve its efficacy. The varied surface oxidation of
the particles is achieved by exposing Dex-CNPs to light which initiates a color change from dark
to pale yellow indicating the reduction of Ce4+ to Ce3+. Interestingly we have found that the DexCNPs exposed to light have reduced cytotoxicity towards squamous cell carcinoma cell line
(CCL30) compared to the protected once. Characterization of the same revealed that Dex- CNPs
exposed to light have decreased Ce4+ /Ce3+ surface oxidation ratio compared to the other. This
provides more insight in useful synthesis of Dex-CNPs in terms of storage and handling. In
summary, higher Ce4+ /Ce3+ surface oxidation ratio is more efficient in hindering tumor growth
by effectively hindering the tumor-stoma interaction.
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CHAPTER ONE: INTRODUCTION

Malignant melanoma is the sixth most common cancer diagnosed in the United States and
one of the most aggressive type of malignant skin cancer which results from the unrestrained
growth of melanocytes. Nanoparticles have proven to be novel material in the field of
nanomedicine. Nanoparticles have potential novel application in drug delivery systems with
therapeutic abilities. The application of cerium oxide nanoparticles (CNPs) coated with polymer
are proven to be promising approach to exhibit anticancer activity which is attributed to its ability
to change the oxidation states mediated at the oxygen vacancies.
Surgery, chemotherapy and radiation are some of the successful techniques in killing
tumor cells. However, in these techniques, it is not easy to distinguish tumor cells from the healthy
once which

inadvertently get exposed to chemical agent/radiation. Therefore it is required to

develop an anti-cancer agent which selectively kills the cancer cells, while still protecting the
normal tissues. In our preliminary work, we have shown that Dextran (1000Da) coated cerium
oxide nanoparticles (Dex-CNPs) selectively kills the cancer cells (50% killing at a concentration
of 150µM) without inducing toxicity to normal cells. Ceria nanoparticles (CNPs) have proved to
be potential redox active radical scavenging agents that can act as antioxidant which is attributed
to its redox nature of switching the oxidation states from +3 to +4 mediated at the oxygen
vacancies on the surface. CNPs are highly active and complex regenerative system that have
potential significance in targeted drug delivery. The selectivity can be understood to efficiently
treat cancer cells. The key physiochemical properties of Dex-CNPs play an important role in
determining its interaction with microenvironments. The in vitro and in vivo evaluation of CNPs
2

on human melanoma cells showed selective pro-oxidative and anti-oxidative properties. It has
been also proved that the CNPs prevent the growth of tumor in vivo and the application of the
antioxidant redox active nanoparticles have formed a new platform in the treatment and
prevention of cancers.

1.1 Introduction to CNPs

Cerium oxide or Ceria is a rare-earth oxide material of cerium present in the lanthanide
series. Ceria is mostly known for its application in chemical mechanical polishing, catalysis,
ultraviolet shielding, conversion coating, electrolyte in solid oxide fuel cells etc.[1-4]. It has
been established that the ceria as a nanomaterial has potential application attributed to the fact
that it acts as an oxygen buffering capacity[5]. In recent research it has been proved that ceria
nanoparticles are observed to have antioxidant property which have potential application in
biomedical research[6].
Reactive oxygen species (ROS) are highly reactive chemical molecules that contain
oxygen such as superoxide radicals and peroxides. ROS is a natural byproduct of reactions that
take place in normal metabolism and plays a crucial role in homeostasis and cell signaling [7].
However, due to unusual stress created by the environmental such as UV or heat exposure, the
ROS levels in microenvironments tend to increase intensely resulting in major damage to cell
structures which is also cumulatively referred as oxidative stress[7]. Antioxidants are naturally
existing molecules that scavenge the excess ROS and maintain stability.
Ce can generally exist in two oxidation states; Ce3+ and Ce4+, thereby in case of cerium
oxide nanoparticles Ce3+ and Ce4+ oxidation states coexist on the surface of the nanoparticles.
3

The function of cerium oxide nanoparticles (CNPs) as antioxidants in biological systems is
attributed to its unique regenerative nature due to low reduction potential and the existence of
both Ce3+ and Ce4+ on their surfaces[8]. The presence of defects in the lattice of ceria
nanoparticles which arises due to the presence of Ce3+ and the oxygen defects that are created
as a result of co-existence of two oxidation states act as reaction sites for catalytic activity. They
are the main reasons for the redox active nature of CNPs. The concentration of the oxygen
defects increase with the decrease in size of CNPs[9]. The switching of oxidation states from
Ce3+ to Ce4+ and vice versa renders them regenerative in nature and this regenerative nature
gives them the capability to perform as potential antioxidants[10]. CNPs are tested in various
environments associated with oxidative stress.
The ratio of Ce3+/Ce4+ indicated the surface chemistry of ceria which is highly regulated
by the microenvironment around the nanoparticles[9, 11]. Thereby, the method of synthesis and
the microenvironment present around the particles play a crucial role and regulate the properties
of CNPs in terms of bioactivity and cytotoxicity[12]. The physical properties of CNPs such as
size, agglomeration, coating etc. influence its interaction with biological substrates and
entities[11]. The surface chemistry of particles which is mainly regulated by the ratio of Ce3+ to
Ce4+ effect the interaction of the particles in biological environment[12]. The redox nature of
switching of oxidation states between +3 and +4 plays an important role in scavenging of
reactive oxygen species and nitrogen species[10, 13-15]. CNPs are found to be effective against
pathologies associated with chronic oxidative stress and inflammation. CNPs are well accepted
in both biological models of in vitro and in vivo, which indicates the potential application of
CNPs in nano-biomedicine and regenerative medicine [16-22] .
4

The reduction of Ce4+ to Ce3+ produces oxygen vacancies on the surface of the crystalline
lattice structure of the nanoparticles which provides active sites for redox reactions to occur.
The kind of specific catalytic reaction depends majorly on the ratio of Ce3+ to Ce4+ [12, 14, 23].
Figure 1 [16]depicts the regenerative cycle of CNPs from Ce3+ to Ce4+ and vice versa in an
attempt to scavenge ROS.

Figure 1: The regenerative cycle of CNPs by switching its oxidation states from 3+ to 4+ and
vice versa to scavenge ROS[16]

It has been well established that the higher concentration of Ce3+ on the surface is more SOD
mimetic in nature[10] and higher concentration of Ce4+ on the surface of the is more catalase
mimetic in nature[13, 24]. Hydrogen peroxide is considered generally to be a toxic byproduct of
the process of respiration, which is generated in the process of scavenging SOD. The eukaryotic
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cells have different enzymes present within such as catalase, peroxidase, glutathione and
peroxiredoxins which in turn regulate the amounts of H2O2. CNPs which have 9% of Ce4+ have
shown to protect rat nerve cells from H2O2 induced cell death [25].

CNPs with higher

concentrations of Ce4+ scavenge H2O2 and regulate its concentrations in microenvironment,
thereby exhibiting catalase mimetic activity[13] [12]. In table 1, the bio-activity of CNPs have
been clearly presented based on the concentration of Ce4+ and Ce3+ [8, 10, 13, 14, 16, 26-31].

Table 1: Summary of catalytic activity of CNPs and its correlation with physiochemical
properties and surface chemistry.

The coating of nanoparticles with biocompatible polymers helps increase the dispersion
stability of nanoparticles and reduces the possible adverse effects of the nanoparticles. The
presence of biocompatible polymers reduce the non-specific interaction of nanoparticles with
cells and proteins there by increasing their time of circulation in the bloodstream in in vivo
studies. Some of the biocompatible polymers that have been studied to coat the CNPs are
6

Dextran (Dex), oleic acid, PAA (poly-acrylic acid), PEG (poly-ethylene glycol) and citric
acid[16]. The synthesis on nanoparticles directly in a matrix of the polymers such as Dex or
PEG helps increase the stability and dispersion of the nanoparticles.

1.2 CNPs Coated with Dextran

Malignant melanoma is one of the most aggressive type of skin cancer which rapidly
increases leading to twice the amount of cases every 10-20 hears[32]. The surgical treatment of
early melanoma has increased success rate though the prognosis of 5- year of survival. However,
in case of advanced melanoma, the success rate is very poor due to the chronic increase in ROS
levels[33]. There is still lack of approach in treating and curing advanced stages of
melanoma[34].
CNPs have proved to be potential redox active radical scavenging agents that can act as
antioxidant which is attributed to its redox nature of switching the oxidation states from +3 to
+4 mediated at the oxygen vacancies on the surface. The use of dextran coated CNPs have a
unique way of exhibiting anticancer activity due to its oxygen vacancies which mediate
chemical activity. Dextran is a complex branched polysaccharide made of glucose molecules. It
is widely used in biomedical application owing to its biocompatible nature.
In our preliminary work, we have shown that dextran coated cerium oxide nanoparticles
(Dex-CNPs) are selectively toxic to tumor cells without inducing toxicity to normal stromal
cells[35, 36]. The cytotoxicity and oxidative stress studies of Dex-CNPs on human melanoma
cells (A375: cancer cells) exhibited reduced cell viability with the increase in nanoparticles
concentration and exposure time of the cells with the nanoparticles. The free radicals generated
7

by Dex-CNPs increased the oxidative stress in resulting in the decrease in cell viability thereby
killing them and reducing the ability of cancer cells to invade. Concentrations of Dex-CNPs
which are non- toxic to stromal cells exhibited cytotoxicity and reduced the invasive nature of
melanoma cells. The in vivo studies on xenograft mice which were performed on
immunodeficient nude mice have proven to decrease the tumor weight and volume after
successful treatment with Dex-CNPs. This can be clearly seen in figure 2, where we can observe
a significant lowered tumor growth and tumor volume to 75% (1day) & 85% (10 day) in contrast
with mock treated controls which indicates a positive effect on in vivo inhibition of the growth
of malignant melanoma [36].

Figure 2: Group 1 mice were vehicle treated, group 2 & 3 were treated with Dex-CNP after 1
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and 10 days of tumor injection respectively. Particles were injected every alternate day and
tumor was dissected after 30 days post tumor injection[36]

In cell biology, the connective tissue cells of any organ are known as stromal cells. The
communication between stromal cells and tumor cells is identified to play a vital role in the
progression and growth of cancer [37]. There by the interaction of tumore and stromal cells play
an important role in the progression of tumor. Myofibroblasts which are the key for tumor
progression, proliferate the miroecosystem of reactive stroma, the formation of myofibroblasts is
facilitated by the transforming growth factor b1 (TGFb1) which are derived from tumor, initiate
the expression of alpha-smooth muscle actin (a biomarker for myofibroblastic cells) which
depends on a reactive oxygen species cell type. The presence of antioxidants prevents the
formation of myofibroblasts, though they encourage the aggressive behavior of tumor cells. In a
previous study, it has been established that the Dex-CNPs affect the formation of myofibroblasts,
thereby regulating the tumor invasion[36]. CNPs have proven to down regulate the invasion of
tumor cells and expression of alpha-smooth muscle actin positive myofibroblastic cells. The
schematic to represent the properties of Dex-CNPs are presented in figure 3.

9

Figure 3: Anticancer activity of cerium oxide nanoparticles. (A) CNPs inhibit myofibroblasts
and invasive effect of squamous tumor cells.

Another very important finding of this study was the Dex-CNPs were non-toxic to normal
cells, though it exhibited cytotoxicity towards squamous tumor cells decreasing its invasion
properties by 2.3 fold (figure 4). The ROS production increases with the increase in concentration
of Dex-CNPs in squamous tumor cells and there was no variation in ROS in case of normal
cells[35]. This behavior of Dex-CNPs is attributed towards it antioxidant effect of Dex-CNPs.
This provides a promising strategy of chemoprevention of tumor invasion. Dex-CNPs almost
completely eliminate the TGF-b1-triggered α-smooth-muscle actin induction after 24-h
treatment.
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Figure 4: Cell viability of Dex-CNPs on (A) normal cell line (human fibroblast) and (B) on
squamous tumor cells.

1.3 Photo-reduction and storage of Dex-CNPs

Cerium oxide nanoparticles coated with dextran that has been described in the above
section are generally stored in the dark. The size of the CNPs are approximately of 5 nm on
average. The homogeneity and stability of dispersion of nanoparticle suspension are of
primary importance for high performance and preservation of its properties for different
applications[38]. It has been established that the surface energy of small particles is higher
than that of larger particles[39]. Therefore the behavioral characteristics of nanoparticles are
enormously susceptible to small changes in micro-physiochemical milieu such as pH,
temperature, ionic strength, concentration etc. which influences the dispersion stability of the
11

nanoparticles[40]. The attractive Van der Waals forces acting between the particles against
the presence of other forces such as columbic forces which are repulsive in nature induced by
the surface adsorbed species have to be balanced which is required to obtain a stable colloidal
suspension of nanoparticles. Steric or electrostatic stability can be provided to suspensions by
surface functionalization of the nanoparticles or by addition of chemicals to regulate properties
such as ionic strength, and pH or [41, 42]. In a previous study using just CNPs with high
concentration of Ce4+, the reversal of surface charge of CNPs was observed with respect to
time, concentration, temperature, and doping. The change was then correlated to the surface
modification of CNPs in aqueous solution and the ion exchange reaction between the surface
protons (H+) and the neighboring hydroxyls ions (OH-). It has been demonstrated that the
adsorption of H+ ions on the surface of CNPs is kinetically more favorable while the
adsorption of OH- ions on CNPs is thermodynamically more favorable using density
functional theory (DFT) calculations.
Dextran plays the role of stabilizing the suspension of CNPs by maintaining the apt
pH, and concentrations. Dex-CNPs is a stable transparent yellow colored solution. Accidently
when once exposed to the room light, the solution turned to pale yellow. In this study we shall
observe the changes in the physiochemical properties of Dex-CNPs which are induced by
exposure to room light. It is observed that a change is the surface oxidation state of the
particles is achieved by exposing Dex-CNPs to light initiating a color change from dark yellow
to pale yellow which was studied to be the reduction of Ce4+ to Ce3+ state. This leads to major
changes in the surface chemistry of CNPs, thereby changing its antioxidant capacity. This
demonstrates the storage and handling of Dex-CNPs which should be stored in dark places to
12

protect its bioactivity and functionality. Time based study of exposure of the Dex- CNPs to
light have been studied in terms of its size, surface charge and the UV- Absorption study. The
bioactivity is tracked on weekly basis to understand the antioxidant capacity with time of
exposure to room light. Another set of experiments were conducted by exposing Dex-CNPs to
high intensity visible light using a xenon lamp. In this study the importance of selecting CNPs
with appropriate surface chemistry and the implications of dynamic changes in its
physiochemical properties are exemplified in terms of biomedical application.

13

CHAPTER TWO: METHODOLOGY

The dextran coated CNP solution is exposed to room light for extended periods of time.
Several characterization techniques have been used to understand the change of oxidation states
and the bioactivity of the CNPs in dextran with days of exposure to light. UV- Visible
spectroscopy is used to measure the rate at which Ce4+ gets reduced to Ce3+. The size of the
particles are recorded. The pH changes and weekly change in the color of the solution are also
recorded. The % of antioxidant capacity of the Dex-CNPs are been measured using Superoxide
dismutase mimetic activity assay and catalase mimetic activity assay. Later experiments are
conducted by shining high powered visible rays using xenon lamp to expedite the whole process,
the above mentioned characterization techniques were used to confirm the change using this
process.

2.1 Dynamic Light Scattering Measurements

Dynamic light scattering phenomenon was used to measure the size of the CNPs. The
instrument used here was a Zeta Sizer Nano ZS by Malvern. The size of nanoparticles were also
measured approximately every week to see the changes in the stabilization of the solution.

2.2 X-Ray Diffraction

The X-ray diffraction patterns were collected using Rigaku D/MAX XRD with CuKα
source (λ=0.1541 nm) at a scan rate of 0.01°/step over 20-70° (2θ) range.

14

2.3 Ultra Violet- Visible Spectroscopy

Ultra Violet- Visible Spectroscopy was used to detect the presence of the oxidation states
of ceria on the Dex-CNPs solution. The Dex-CNPs have almost 60% of Ce4+ state in it and then
gets reduced. The rate of reduction can be clearly calculated form the peak corresponding to the
+4 state of cerium obtained in the spectra. The signature peak of Ce4+ is around 290nm.

2.4 X-ray Photoelectron Spectroscopy

X-ray photoelectron spectroscopy is used to measure the ratio of Cerium in +3 state to
Cerium in +4 state. This can be used to know the ratio of the oxidation states of ceria every week
and the rate of change of switching of the oxidation states can also be calculated. XPS experiments
were carried out using Physical Electronics (PHI5400 ESCA) spectrometer with a monochromatic
Al Kα X-ray source operated at 300 W and a base pressure of 5×10-8 torr. The acquisition time of
the sample was kept low to minimize any surface oxidation state changes under X-ray irradiation.

2.5 Anti-oxidant Mimetic Activity

The anti-oxidant mimetic activity of the Dex-CNPs with the time of exposure were
measured using assays. Superoxide dismutase (SOD) mimetic activity was determined by using a
SOD assay kit and the catalase mimetic activity was determined using Amplex Red assy.
2.5.1 Superoxide Dismutase Assay
The superoxide dismutase activity was measured using a superoxide dismutase assay
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kit. SOD assay kit-WST allows a useful SOD assaying by utilizing Dojindo’s highly watersoluble tetrazolium salt, WST-1 (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl) 2H-tetrazolium, monosodium salt) that produces a formazan dye (which is water soluble) on
reduction when in contact with a superoxide anion. The rate of the reduction with O2 are linearly
related to the xanthine oxidase (XO) activity, and is inhibited by SOD. Pure water is used as
the control to compare against the Dex-CNPs. The measurements are taken approximately
every week to the change in the SOD mimetic activity. The reaction of water and DEX-CNPs
with the WST-1is tested to prevent the reduction by the control and the sample to form the
formazan dye. The experiment is conducted in a 96 well plate and the absorbance of the dye is
read using an Ultra Violet- Visible spectroscopy. The percentage of inhibition of the radical
species by the Dex-CNPs can be calculated every week by running the assay on the sample
which gives an in depth understanding of the change in bioactivity of the Dex-CNPs with the
time of exposure to room light. The rate of scavenging of the oxygen radical species can be
derived using the data measured. Thereby we can calculate the reaction kinetics of SOD
mimetic activity.
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Figure 5: Principle of the SOD Assay Kit and the structure of WST-1 (2-(4-Iodophenyl) - 3-(4nitrophenyl)-5-(2, 4-disulfophenyl) - 2H-tetrazolium, monosodium salt).
Source: 19160 SOD determination kithttp://www.sigmaaldrich.com.

2.5.2 Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit
The amplex Red hydrogen peroxide/peroxidase assay kit contains a sensitive, one-step
assay that uses the amplex red reagent (10-acetyl-3, 7-dihydroxyphenoxazine) to detect
hydrogen peroxide (H2O2). The amplex red reagent, in combination with horseradish
peroxidase (HRP), has been used to detect H2O2 released from biological samples, including
cells. Furthermore, the amplex red reagent can be used as an ultrasensitive assay for peroxidase
activity when H2O2 is in excess. Pure water is used as a control against the Dex-CNP solution.
The concentration of CNPs used to run the assay is 1mM. Hydrogen peroxide is incubated
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with the samples for time durations of 0 min, 10 min, 20 min and 30 min. The dye is finally
added to see is added and the absorbance of the reduced dye was read under a UV-Visible
spectroscopy plate reader. The kinetics of the reaction was observed for 30 min and the
corresponding readings were collected.
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CHAPTER THREE: RESULTS AND DISCUSSION

3.1 Introduction to Photo-reduction of Dex-CNPs

Cerium oxide nanoparticles in presence of dextran selectively kill the cancer cells (40%
killing at a concentration of 250μM) without inducing toxicity to normal cells. The hydrodynamic
size is about 5-7nm. Cerium oxide nanoparticles were prepared in 0.5% solution of dextran (MWt
1000Da) to obtain dextran coated cerium oxide nanoparticles (Dex-CNPs) as depicted in figure
6. The preparation is tailored to have higher concentration of Ce4+ than Ce3+ on the surface of the
nanoparticles
Dex-CNPs which exhibit a selective toxicity towards cancer cells is stored in generally
stored in dark. In this study, the solution of Dex-CNPs was exposed to room light (visible white
light: 390-700nm).and the photo-reduced samples of Dex-CNPs were characterized thoroughly
to understand the effect of the exposure of room light with time. The change in properties of the
system with the time of exposure are illustrated and discussed in detail in this chapter. This
provides an insight about the interaction of dextran with CNPs and the change in the properties
and functionality of the system. Initially an accidental exposure of the sample to light has led to
the start of the study where the samples were characterized after eight weeks of exposure to the
room light. The understanding of the change in properties has been enhanced by a systematic
approach of recording the changes every week to observe the continuous changes in the
properties and functionality of the system. To further enhance our understanding, the above
process of exposing the Dex-CNPs to room light has been expedited by shining high intensity
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visible light using a high powered xenon lamp. The above three mentioned scenarios have been
discussed in detailed in the sections below.

Figure 6: Schematic representing the dextran polymer molecule coated on cerium oxide
nanoparticle

3.2 Photo-reduction of Dex-CNPs

Dex-CNPs stored in the dark is a stable transparent yellow colored solution. On
exposing the solution to room light, the color of the solution changes to pale yellow with the
presence of precipitation of dextran and CNPs. The room light corresponds to the exposure to
tube lights installed in the lab (Sylvania Octron 3500k f032 735 eco). This indicates that
dextran no longer helps in the stabilizing the dispersion of CNPs in the matrix of dextran. This
visible change in color and stabilization of the solution of Dex-CNPs is presented in figure 7.
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This poses a serious storage and handling issue of Dex-CNPs to preserve it chemical and biofunctional properties.

Figure 7: Schematic showing the change in the color of Dex-CNPs from dark yellow to pale
yellow on exposing to normal tube light after 60 days

The figure 7 shows the color change of the Dex-CNPs before and after exposure to the
room light. The schematic also represents the change in color of the solution on exposure to
light. There is an immediate change in the color in the first seven days and eventually the color
turns to pale yellow with the increase in the exposure time of the solution. There is a clear
presence of turbidity of the sample indicating the precipitation of dextran in the solution. This
precipitation of dextran is also attributed to the change in pH of the solution due to the photoreduction of CNPs.
3.2.1 X-Ray Diffraction Analysis
The X-Ray diffraction spectrum of Dex-CNPs stored in the dark (Dex-CNPs Dark) and
Dex-CNPs exposed to room light for 60 days (Dex-CNPs Light) have been collected. Cerium oxide
has a fluorite structure with and it has signature peaks corresponding to the planes (111), (200),
(220), (311), (222), (400) and (331). The peaks corresponding to (111), (200), (220) and (311)
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planes are retained when coated with dextran and the exposure to the light did not disturb the
crystallanity or structure of the cerium oxide nanoparticles. The broadening of the peak in case of
Dex-CNPs Dark and Dex-CNPs light is due to the smaller sized crystal. This indicates that there is
no change in the intrinsic structure of the Dex-CNPs on exposure to light.

Figure 8: X-Ray Diffraction (XRD) spectra of bare cerium oxide nanoparticles, Dex-CNP dark
and Dex-CNP light. The XRD spectrum of Dex-CNP dark and Dex-CNP light are similar to each
other indicating similar crystallanity and structure of the nanoparticles.

3.2.2 Transmission Electron Microscopy
Transmission electron microscopy (TEM) was used to observe the size and stability of the
Dex-CNPs before and after the exposure of the light. The Dex-CNPs stored in the dark are well
dispersed and crystalline in nature indicating that there is no presence of agglomeration. On the
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other hand, in the case of Dex-CNPs Light, the particles get agglomerated with the exposure of the
light and the crystalline nature, shape and size of the nanoparticles is still intact. The overlapping
of particles is clearly seen in case of Dex-CNPs Light indicating agglomeration. The structure,
crystallanity, shape and size of the nanoparticles have been preserved indicating only change in
morphology with the exposure to light.

Figure 9: Transmission electron microscopy images of Dex-CNP Light (B) compared to the DexCNP Dark (A) were analyzed. The structure, shape and size of Dex-CNP dark and Dex-CNP
light are similar exhibiting only change in morphology indicating agglomeration in case of DexCNPs Light.

3.2.3 Fourier Transform Infrared Spectroscopy Analysis
Fourier transform infrared (FTIR) spectroscopy is performed on Dex-CNPs both stored in
light and dark. The CH2 stretch, C-O-H vibration, C-O stretch and C-C stretch are present in all
of only dextran, Dex-CNP Dark and Dex-CNP Light. The peak corresponding to C=O stretch is
present only in the solution go Dex-CNPs that is exposed to light. This indicated the formation
of an aldehyde or a ketone bond that could have formed as a result of possible oxidation of dextran
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in presence of cerium oxide nanoparticles which themselves exhibit reduction from Ce4+
oxidation state to Ce3+ on the surface of the nanoparticles.

Figure 10: The FTIR of dextran, Dex-CNP dark and Dex-CNP light indicates the properties of
the coating of dextran on CNPs when compared to the bare CNP. It is observed that the peaks
corresponding to CH2 stretch, C-O-H vibration, C-O stretch and C-C stretch are present in both
Dex-CNP light and dark except C=O stretch which is present only when the sample is exposed to
light indicating the possibility of oxidation of dextran when exposed to the light.

The possible routes for the oxidation of dextran are presented in figure 11. In the case of oxidation
by route A, the C3 and C4 carbons are attacked where as in route B C2 and C3 carbons are attacked
to form aldehyde. It is assumed that this is a possible mechanism of oxidation of dextran, the
presence of aldehyde group can be using NMR (Nuclear magnetic resonance) analysis for future
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work. The reduction of Ce4+ and the oxidation of dextran might form a redox system due to the
prolonged exposure of light which have to be proved using electrochemical experiments.

Figure 11: Schematics illustrating the two different possible routes of oxidation of dextran to
form aldehyde in presence of cerium oxide regenerative nanoparticles. In case of route A, the C3
and C4 carbons are attacked and in route B C2 and C3 carbons are attacked.

3.2.4 Ultra Violet- Visible Spectroscopy Analysis
The ultra violet- visible spectroscopy (UV-Vis Spec) was performed on Dex- CNPs
solutions before and after the exposure of light to see the change in oxidation states of the cerium
ions present in the cerium oxide nanoparticles. The change is depicted very clearly in figure 12.
The Dex-CNPs solution stored in the dark is denoted by Dex-CNP Dark and the solution exposed
to light is denoted by Dex-CNP Light. The Ce4+ signature peak is at 285 nm which shifts to 293
nm in case of samples exposed to light indicating the change in band gap. The band gap of DexCNPs Dark is 2.9 eV compared to 2.72 eV of Dex-CNPs Light indicating a red shift due to the
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decrease in band gap . The decrease in band gap could be due to the increase in size of the DexCNPs arising from the precipitation. This illustrates a pronounced change in the electronic
properties of the dextran coated CNPs in presence of light.
The decrease in the absorbance values of the peak corresponding to Ce4+ indicates the
decrease in concentration of Ce4+ as concentration of the species is directly proportional to the
absorbance value of its peak in UV-Vis spec. This correlation is given by Beer-Lamberts Law
which is stated below:

Here A is the absorbance, ℓ is the distance the light travels through the material (i.e., the path
length). The absorption coefficient α can, in turn, be written as a product of molar absorptivity of
the absorber, ε (extinction coefficient), and the molar concentration c of absorbing species. The
decrease in concentration of Ce4+ directly indicates the increase in concentration of Ce3+. This
clearly indicated the reduction of Ce4+ to Ce3+ on the surface of Dex-CNPs due to the prolonged
exposure to the light. This is a unique phenomenon which leads to the change in surface chemistry
of the CNPs is possible only in presence of dextran due to the exposure to light.
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Figure 12: The UV-Vis spectra of Dex-CNP stored in the dark compared to DEX-CNP exposed to
light. The spectra indicates the reduction in concentration of Ce4+to Ce3+ leading to a change in
surface chemistry of CNPs when the solution is exposed to light. Additionally the spectra indicates
a red shift due to the light exposure from Dex-CNP Dark to Dex-CNP Light.

3.2.5 X-Ray Photoelectron Spectroscopy Analysis
X- Ray photoelectron spectroscopy is used to analyze the dynamic surface chemistry of the
cerium oxide nanoparticles in presence of dextran with the increase in exposure time of the system
in room light. The surface chemistry of the cerium oxide nanoparticles depends on the ratio of Ce3+
to Ce4+. The Ce3+/Ce4+ increases with the increase in time of exposure of the sample in room light.
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The Dex-CNPs stored in the dark has 79% of Ce4+ which decreases in the sample exposed to light
to 33% of Ce4+. This indicates a drastic change in the surface chemistry of CNPs in presence of
dextran when exposed to room light for almost 60 days. The peaks at 880.8, 885.8, 899.3 and
903.5eV corresponding to the Ce3+ oxidation state and peaks at, 881.9, 888.4, 897.9, 901.2, 906.8
and 916.3eV corresponding to the Ce4+. The increased amount of Ce3+ in case of Dex-CNPs Light
is the marked characteristic of the sample and a major change in the surface chemistry of the
nanoparticles.

Dex-CNP Dark

Dex-CNP Light

Figure 13: Representative peak-fitted X-ray photoelectron spectroscopy (XPS) spectrum of Ce
(3d) in Dex-CNP Dark and Light. The XPS analysis indicates the increased ratio of Ce3+/Ce4+ in
case of Dex-CNP light which is the marked characteristic difference between Dex-CNP dark and
light. Dex-CNP light has 79% Ce4+ compared to 33% of Ce4+ in Dex-CNP Light which indicates
a significant reduction of Ce4+ to Ce3+ in presence of light.
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3.2.6 Cytotoxicity Studies
The toxicity studies of Dex-CNPs Dark and Light were performed on both normal cell line
and skin cancer cell line. The normal cell line used for this study was HUVEC (Human Umbilical
Vein Endothelial Cells) cell line and the skin cancer cell line was human squamous cell carcinoma
cell line (CCl-30). The cytotoxic effects of Dex-CNPs Dark and Light was measured using MTT
(3- (4, 5- Dimethylthiazol- 2- yl) -2, 5 -diphenyltetrazolium bromide) assay. The presence of active
mitochondrial dehydrogenases, is an indicator of cellular viability, which results in formation of a
purple color formazan dye. Briefly, MTT solution (0.5 mg/ml) was added to the cell cultures treated
for 24 hours with the nanoparticles. The medium was removed and the cells after the addition of
the dye and lysed in presence of dimethyl sulfoxide. The formazan formation was measured at 570
nm. The results are presented as percentage of untreated control which was set at 100%.

3.2.6.1 Toxicity using HUVEC Cell Line
The toxicity of dextran, Dex-CNPs Dark and Dex-CNPs Light are evaluated in in vitro
environment using normal human cell line to see if they are toxic to the normal cells. It can be
clearly seen in figure 14 that the dextran, Dex-CNPs Dark, Dex-CNPs Light are not toxic to the
cells. It can be concluded that the concentrations up to 100µM are non-toxic to the cell line. The
dextran did not exhibit any toxicity even at 100 µM whereas there is 10% toxicity in case of DexCNPs Dark and Dex-CNPs Light.
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Figure 14: Cell viability of Dex-CNP light and Dex-CNP dark were performed using normal cell
line. The dextran control, Dex-CNP light & Dex-CNP dark do not exhibit any toxicity towards
HUVEC (Human Umbilical Vein Endothelial Cells) cell line in in vitro up to a dosage of 100μM.

3.2.6.2 Toxicity using CCL 30 Cell Line
The toxicity of dextran, Dex-CNPs Dark and Dex-CNPs Light are evaluated in in vitro
environment using skin cancer cells. The Dextran control & Dex-CNP light did not show any
toxicity to CCL-30, though Dex-CNP dark exhibited 40% killing of skin cancer cells at 200250μM of dosage. Dex-CNP Dark (79% Ce4+) is not cytotoxic to normal cell line but is toxic
to cancer cell line unlike Dex-CNP light which is not cytotoxic to both the cell lines. This bifunctionality of Dex-CNPs exhibiting toxicity to cancer cells and non-toxicity to normal cells
is attained at only higher concentrations of Ce4+. This proposes that the interaction of DexCNPs inside the cancer cells changes drastically due to the change in surface chemistry of the
particles resulted from the prolonged exposure to room light. The Dex-CNPs dark get activated
in the cancer cells due to the lowered pH in the (approximately in the range of 4 to 6).

30

Figure 15: Cell viability studies were conducted on Dex-CNP dark and Dex-CNP light using
human squamous cell carcinoma cell line (CCl-30). The dextran control & Dex-CNP Light did
not show any toxicity to CCL-30, though Dex-CNP Dark exhibited 40% killing of skin cancer
cells at 200- 250μM of dosage.
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3.3 Time Based Study of Photo-reduction of Dex-CNPs

A systematic time based study of photo-reduction of Dex-CNPs was performed by
recording the characteristic change in properties of Dex-CNPs with increase in time of exposure
to room light. One of the major visible changes observed is the change in the color of the samples
as mentioned before in section 3.2. This change is clearly depicted in figure 16, where the stable
yellow color solution of Dex-CNPs turns pale yellow with significant increase in turbidity
indicating the precipitation of dextran and CNPs. The dextran which helps the CNPs to form a
stable solution precipitates after 7 days of exposure to room light of the room.

Figure 16: Images depicting the change in color of Dex-CNPs with increase in days of exposure
of the sample to room light. There is a clear precipitation of dextran on day 7.

There is a clear change in pH of the solution which led of the precipitation and instability
of the solution due to the exposure of Dex-CNPs to light. The change in pH is depicted in figure
17. This indicates that the photo-reduction of Dex-CNPs changes its pH starting from basic pH
of 8.18 on day 0 to acidic pH of 6.14 on day 60. The increase in H+ ion concentration marked by

32

the decrease in pH might be due to the oxidation of dextran to form aldehyde bonds which release
two H+ ions from a single monomer as indicated in section 3.2.3.

Figure 17: The graphs shows the change in pH of the Dex-CNPs with the increase in days of
exposure of Dex-CNPs to room light.

3.3.1 Dynamic Light Scattering Measurements
Dynamic light scattering (DLS) phenomenon was used to measure the size of the CNPs.
The size of the nanoparticles were measured approximately every week to see the changes in the
stabilization of the solution. The size of the nanoparticles in presence of dextran increases with the
increase in exposure time in the light. This is clearly due to the change in pH of the solution and the
oxidation of dextran leading to its precipitation forming large size agglomerates of around 5000nm.
The initial size of the particles are around 10-12 nm as measured form the DLS though it is around
5-8 nm from the TEM images. In a duration of just 7 days the size of the particles becomes around
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5000nm due to the precipitation of dextran.

Figure 18: The size of the Dex-CNPs was analyzed using DLS with time of exposure to room
light. It can be clearly observed that the size of the nanoparticles increases drastically with time
indicating agglomeration.

3.3.2 X-Ray Photoelectron Spectroscopy Analysis
The x-ray photoelectron spectroscopy analysis shows that the surface chemistry of the Dex-CNPs.
The samples were collected every week for the XPS analysis to see the change in the surface
chemistry with the increase in time of exposure of the samples to room light. The surface
chemistry is mainly regulated by the ratio of Ce3+/ Ce4+ or the % of Ce4+ of the surface. In figure
19, we can observe that the concentration of Ce4+ decreases with increase in time of exposure of the
sample to light till day 28 and then starts to increase. This may be attributed to the intrinsic property
of CNPs to be redox active. This phenomenon attributes to the regenerative nature of the CNPs
undergoing the cycle of increase and decrease in the concentration of Ce4+.
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Figure 19: The graph depicting the decrease in concentration of Ce4+ concentration with
increase in time of exposure to room light till day 28 and the later increase in the concentration.

3.3.3 Ultra Violet- Visible Spectroscopy Analysis
The UV-Vis spectra were collected with respected to the time of exposure of the DexCNP solution. It clearly depicts the decrease in Ce4+ concentration, thereby implying the increase
in Ce3+ concentration indicating the reduction of Ce4+ ions. The spectra was collected every week
to get a clear idea of the rate of reduction of Ce4+ in the system. This is in correlation with the
decrease in Ce4+ peak observed in section 3.2.4. The peak of Ce4+ drift to the right in the spectra
which indicates the red shift with the decrease in the indirect band gap. The later increase in
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concentration of Ce4+ on the surface of CNPs is not observed in case of UV-Vis analysis owing
to the precipitation of the sample. The fact that the dextran precipitated interferes with the UVVis Spec measurements as the exposed volume to the beam might not contain enough CNPs as
they are precipitated due to disturbed dispersion stability of the sample.

Figure 20: The UV-Vis spectrum of Dex-CNP dark was studied with time by exposing in to light
to form DEX-CNP light. The different graphs correspond to the collection of data on different
days. The spectrum clearly indicates the decrease in the concentration of Ce4+ with time.

The change in indirect band gap with the time of exposure of Dex-CNPs to light has been
presented in figure 21. The indirect gap is calculated using the x intercept of the graph between

(ahν)0.5 vs hν, where ν is frequency = c/λ, c is the speed of light and h is the planks constant.
The slope of the peak corresponding to Ce4+ is taken to calculate the x intercept. The indirect
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band gap corresponding to Ce4+ decreases with the increase in days of exposure of Dex-CNPs to
room light indicating a clear red shift. This is in correspondence to results obtained in section
3.2.4.

Figure 21: The change in indirect band gap corresponding to Ce4+with the increase in days of
exposure of the sample to room light indicating a red shift.

The decrease in absorbance value corresponding to the concentration of Ce4+ with the
increase in days of exposure to room light, is depicted in figure 22. This graph shows that the
concentration of Ce4+ decreases by approximately 62.5% in a span of 60 days of exposure of
Dex-CNPs to room light, indicating a significant decrease in the concentration of Ce4+ oxidation
state. This gives us an estimate of rate of reduction of Ce4+ to Ce3+
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Figure 22: The absorbance value of peak corresponding to Ce4+ obtained from UV-Vis Spec
indicating the decrease in concentration of Ce4+ oxidation state by 62.5% in a span of 60 days of
exposure of Dex-CNPs to room light.

3.3.4 Bio-activity of Dex-CNPs: Superoxide Dismutase Assay Analysis
Superoxide dismutase (SOD) is a naturally existing enzyme that catalyze the dismutation
of superoxide radical to break it down into oxygen and hydrogen peroxide. Thus, they are an
important antioxidant defense in nearly all cells that are exposed to oxygen. The superoxide
dismutase (SOD) assay kit was used to detect the SOD mimetic activity of the cerium oxide
nanoparticles in presence of dextran. The superoxide radical to be scavenged in the given SOD
assay kit is O2−·, the superscript of a dot represents the radical in the superoxide radical. The reagent
used in the assay, WST-1 reduces to form a formazan dye in presence of superoxide radical. The
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superoxide radical scavenging ability of Dex-CNPs increases with the increase in time of exposure
of the sample in light. The control used here is water which has the highest absorbance owing to
the fact that water is not SOD mimetic and the superoxide radicals present are all scavenged using
WST-1 to form the formazan dye. The sample at day 0 is the Dex-CNPs stored in the dark which
are slightly SOD activity with a decreased absorbance of formazan dye to the consumption of
superoxide radicals by the CNPs as shown in figure 22. The shaded area corresponds to area covered
by error of the y axis. The assay is run for 20 cycles and the duration of each cycle is 60 seconds.
The reaction kinetics are presented below for the whole duration of the assay. The scavenging
ability of Dex-CNPs increases with the increase in the time of exposure of the sample in light. This
can be observed by the curve shifting away from the control.
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Figure 23: The SOD mimetic activity of the Dex-CNPs are measured suing the SOD assay kit.
The graph revels the reaction kinetics of the nanoparticles with the superoxide radicals
indicating the increase in SOD mimetic activity of the Dex-CNPs with the increase in exposure
time with light.

The rate of inhibition of the superoxide radical at a given time of exposure to the light can
be calculated by subtracting each of the kinetic curves from the control curve. Here, the assumption
made is that at a given time of recording the kinetics the amount of superoxide radical scavenged
by the CNPs in Dex-CNPs is proportional to the difference of absorbance of formazan dye between
the control sample and Dex-CNPs. The rate of inhibition of O2- decreases as the solution is exposed
more to the light and after a threshold time of exposure of almost 34 days the rate again increases.
This is in consistent with the increase of the SOD mimetic activity and then a decrease after 34
days.
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Figure 24: The rate of inhibition of O2 with time of time of reaction with the dye in presence of
the superoxide radicals. The assay was read in the UV-Vis spec for 20 cycles each of one minute
to get kinetics data. Different plots are made for different days of exposure of room light.

CNPs mimic SOD posing them as potential antioxidants [6]. The % of antioxidant capacity
was measured for all samples exposed for different durations to the room light. In the figure 25 the
% of antioxidant capacity increases till day 34 and then decreases with the days of exposure of the
sample in room light. This is in consistent with the rate of inhibition of the superoxide radical and
the corresponding kinetics. The % of antioxidant capacity was calculated against the control and at
the end of 20 minutes of the absorbance reading. Dex-CNPs to start with has more Ce4+ concentration
than Ce3+ indicating that it is more catalase active[13]. It has been well established that the high
concentrations of Ce3+ on the surface of CNPs leads to increased SOD mimetic activity[10]. The
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concentration of Ce4+ decreases with the time of exposure of the sample to light indicating the
decrease in catalase mimetic activity and increase in SOD mimetic activity. The initial increase in
SOD mimetic activity can be correlated to the initial decrease in concentration of Ce4+ from XPS and
the later decrease in activity is in correspondence to the increase in concentration of Ce4+
concentration. This can be further confirmed clearly from section 3.3.5

Figure 25: The graph depicts the initial increase in % of antioxidant capacity of the Dex-CNPs
with the exposure to the room light which later decreases after 34 days.

3.3.5 Bio-activity of Dex-CNPs: Amplex Red Assay Analysis
The catalase mimetic activity is the measure of ability of the nanoparticles to scavenge
hydrogen peroxide. Dex-CNPs have catalase mimetic activity to start with on day 0 due to the
increased amount of Ce4+ in the system. Due to the exposure to the room light the concentration of
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Ce4+ decreases and the concentration of Ce3+ increases which indicated that the decrease in catalase
mimetic activity with time. This is confirmed by figure 26 which depicts the reaction kinetics of
samples exposed to room light at different durations. It can be clearly observed that control as the
highest absorbance which means that the dye has scavenged all the hydrogen peroxide in the
solution. The control sample used for this assay is water.
The day 0 corresponds to the Dex-CNPs stored in the dark which have the highest catalase
mimetic activity as it has the lowest absorbance which indicated that the major portion of the
hydrogen peroxide is scavenged by the CNPs in the solution. With the increase in days of
exposure to the room light, the catalase mimetic activity of Dex-CNPs decreases which is
indicated by the fact that the curves come closer to the control which is not catalase mimetic. The
reaction kinetics are recorded after the incubation of Dex-CNPs with hydrogen peroxide for 30
min and then the dye was added. The absorbance changes were read in a UV-Visible Spec for
another 30 minutes to record the reaction kinetics. The catalase mimetic activity again increases
after day 28. The point of change from decrease to increase in catalase mimetic activity (i.e. day
28) and the point of change of increase to decrease SOD mimetic activity (i.e. day 34) do not
match perfectly. It can be still concluded that the both are related inversely proportional to one
another regulated by the change in concentration of Ce4+.
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Figure 26: The reaction kinetics of scavenging of hydrogen peroxide of dye corresponding to
catalase activity of the Dex-CNPs. The data is recorded for different days of exposure to light.

The % of antioxidant capacity to scavenge hydrogen peroxide at the end of 30 minutes of
recording of the reaction kinetics are depicted in figure 27. The catalase ability, the % of
antioxidant capacity in terms of scavenging the hydrogen peroxide decrease and then increases
with time of exposure to the light. This indicates the fact that the catalase mimetic activity
decreases with the increase in the concentration of the Ce3+ and the SOD mimetic activity
increases. This can correlated with the decrease in the concentration of Ce4+. The increase in SOD
activity and the decrease in catalase mimetic activity goes hand in hand with the decrease in
concentration of Ce4+ as shown in the XPS analysis (section 3.3.2) and the later decrease in SOD
mimetic and increase in catalase mimetic activity is correlated to the increase in Ce4+ concentration.
This concludes a major change in bio-activity of the Dex-CNPs due to the exposure to just room
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light. This considerably poses a major storage issue for cytotoxicity of cancer cells.

Figure 27: The graph depicts the initial decrease in % of antioxidant capacity of the Dex-CNPs
with the exposure to the room light which later increases after 14 days of exposure to the light.

3.4 Expedited Study of Photo-reduction of Dex-CNPs

We have observed till now that the Ce4+ concentration decreases with the increase in time
of exposure of Dex-CNPs to normal room light. The study that was conducted for 60 days has
been expedited to 25 hours using a high intensity visible light from a high powered xenon lamp.
The xenon lamp was used at a power of 600 Watts. The spectra of mercury (xenon) lamp when
irradiated at 300W, consists of wavelengths in UV as well as in visible region which is depicted
in figure 28.
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Figure 28: Spectra of Mercury (xenon) lamp when irradiated at 300W, consists of wavelengths
in UV as well as in visible region.

The experiments were conducted by taking 70ml of Dex-CNPs in a water jacketed
beaker. The temperature of the water running in the beaker was maintained at 25ºC to keep the
solution at room temperature and avoid any possible heating of the solution due to prolonged
exposures to high powered xenon lamp as shown in figure 29. 2ml of the sample was collected
at different times of exposure to study the change in properties of Dex-CNPs. Samples were
collected after 0 min, 5 min, 15 min, 20 min, 40 min, 60 min, 90 min, 2 hrs., 3 hrs., 4hrs, 5 hrs.,
7 hrs., 9 hrs., 12 hrs., 14 hrs., 16 hrs., 18 hrs., 20 hrs., 22 hrs. and 25 hrs. of exposure to high
intensity visible light.
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Figure 29: Image of the experimental set up of expedited time based study of photo-reduction of
CNPs using a high powered Xenon lamp.

This study reconfirms the changes observed previous in section 3.2 and 3.3. The
significant visible changes observed is the change in the color from yellow color solution to pale
yellow to white precipitate as seen in figure 30. The increase in turbidity indicates the
precipitation of dextran due to its oxidation. The dextran is no longer soluble to form a stable
solution after 9 hours of exposure to high intensity visible light. This change is visible
observation is in correspondence to the previous study in section 3.3.
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Figure 30: Images of the samples collected after certain time of exposure of the sample to high
intensity visible light. The color of the solution changes from yellow to pale yellow to white
turbid precipitate.

3.4.1 Ultra Violet- Visible Spectroscopy Analysis
The UV-Vis spectra were analyzed for all the Dex-CNPs samples exposed for different
durations of time of the solution. The graph in figure 31 corresponds to just the Ce4+ to clearly
observe the decrease in Ce4+ concentration, thereby implying the increase in Ce3+ concentration
indicating the reduction of Ce4+ ions. The corresponding decrease in band gap is depicted in
figure 32 and the decrease in intensity of absorbance of Ce4+ is depicted in figure 33. All the
observations are in correspondence with the results obtained in section 3.2.4 and section 3.3.3.
The change in indirect band gap corresponding to Ce4+ is very similar to the trend obtained in
section 3.3.3. This indicates that the process of photo-reduction in case of normal room light and
high intensity visible light is quite similar. The reduction of Ce4+ to Ce3+ follows an exponential
behavior as depicted in figure 22 and figure 33. Though the band gap values are different and
lower in value compared to the study using normal room light, the trend is similar. This proves
the fact that there is a clear indication of red shift due to the decrease in band gap owing to the
decrease in concentration of Ce4+.
48

Figure 31: The UV-Vis spectrum of Dex-CNP exposed for different durations to high intensity
visible light were studied. The different graphs correspond to the collection of data in the region
corresponding to Ce4+ peak.
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Figure 32: The change in indirect band gap corresponding to Ce4+with the increase in time of
exposure of Dex-CNPs to high intensity visible light indicating a red shift.
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Figure 33: The absorbance value of peak corresponding to Ce4+ obtained from UV-Vis Spec
indicating the decrease in concentration of Ce4+ oxidation state in a span of 25 hours of
exposure of Dex-CNPs to high intensity visible light.

The UV-Vis Spec analysis revealed that the concentration of Ce4+ is decreases indicating
its reduction to form Ce3+ and this change is clearly exponential and the absorbance values can
be fitted by the equation a+

be-cx (where a, b, and c are fitting parameters), which is similar to

the trend in the reduction of Ce4+ in case of exposure to normal room light. The initial slope of
the equation given by the value of c is larger in case of exposure using high intensity xenon lamp
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(c= 4.61*10-3 m-1) compared to that of exposure to normal room light (c= 9.95*10-5 m-1). This
indicates the expedited photo reduction of Dex-CNPs under high powered xenon lamp.

Figure 34: The decrease in absorbance value of peak corresponding to Ce4+ peak following an
exponential trend in case of both exposure to room light and exposure to high powered xenon
lamp.

3.4.2 Bio-activity of Dex-CNPs: Superoxide Dismutase Assay Analysis
The % of antioxidant ability of SOD mimetic activity was only calculated. It clearly indicates
the initial increase in SOD mimetic activity and then the decrease after 4 hours of exposure to high
intensity visible light. The trend that is depicted in figure 35 is clearly similar to that of figure 25
where the samples are exposed to normal room light. This trend marks the bio-activity of DexCNPs on exposure to room light. In this section we have clearly replicated the change of properties
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of Dex-CNPs using a high intensity visible light compared to that of a normal room light. This
result of change in surface chemistry and bioactivity of Dex-CNPs on just the exposure to light for
even few minutes can provide a unique platform for applications in therapeutics using
nanomaterial. Thereby we have concluded that by regulating the time of exposure of visible light,
the surface chemistry and bio-activity of Dex-CNPs can be changed and controlled.

Figure 35: The graph depicts the initial increase in % of antioxidant capacity (SOD mimetic
activity) of the Dex-CNPs with the exposure to high intensity visible light which later decreases
after 4 hours of exposure.
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CHAPTER FOUR: CONCLUSION

CNPs are highly active and complex regenerative system that have potential significance
in targeted drug delivery. In this study, the extreme sensitivity of Dex-CNPs to room light has
been demonstrated. There is a clear indication of photo-reduction of CNPs in presence of dextran
when exposed to room light. The solution of Dex-CNPs was exposed to room light for 60 days
and were characterized thoroughly to understand the effect of the exposure of room light with time.
The solution of Dex-CNPs changes its color from yellow to pale yellow precipitate indicates the
destabilization of the system due to the precipitation of dextran. The exposure to light does not
disturb the intrinsic structure of CNPs with no change in crystallanity or structure demonstrated
by XRD and TEM analysis. The size, shape and crystallanity of both Dex-CNPs are preserved as
seen in TEM images, though there is a clear observation of agglomeration in case of Dex-CNPs
Light. The FTIR characterization revealed that the dextran bonds on Dex-CNPs Light and Dark
remains same expect for the C=O stretch peak which indicates the formation of aldehyde due to
possible oxidation of dextran in presence of CNPs which themselves exhibit reduction from Ce4+
to Ce3+ on the surface of the nanoparticles with the exposure to light. The UV-Vis Spec. results
indicate the decrease in concentration of Ce4+ indicating the reduction of Ce4+ to Ce3+. The band
gap also decreases due to the increase in size of the particles which arises from the precipitation
indicating a red shift. This also projects the major change in the electronic properties of DexCNPs with exposure to light. The XPS studies also support the decrease in concentration of Ce4+
with the exposure to light. The cytotoxicity studies support the original behavior of Dex-CNPs
Dark which are non- toxic to normal cells and cytotoxic to squamous skin cancer cells. On the
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other hand, the Dex-CNPs Light were non-toxic to both normal cells and squamous skin cancer
cells. This indicates a clear photo-reduction of CNPs in Dex-CNPs solution when exposed to
light. The electronic properties, dispersion stability, interaction of CNPs with dextran, surface
chemistry and cytotoxicity of Dex-CNPs change due to the prolonged exposure to normal room
light.
The above study was further confirmed through a systematic time based measurements of
the properties to observe the trend in photo-reduction. It has been observed that the size of the
Dex-CNPs increases drastically due to the precipitation of dextran. The precipitation is observed
after 7 days of exposure to light indicating the loss of dispersion stability of the solution. The
XPS analysis clearly indicates the initial decrease and the later increase in concentration of Ce4+
with the increase in time of exposure of the sample to room light. The UV-Vis spec analysis
indicates the reduction of Ce4+ due to the decrease in concentration of Ce4+ indicating photoreduction. The reduction of Ce4+ to Ce3+ follows an exponential behavior. The SOD mimetic
activity of Dex-CNPs increases till day 34 and then decreases. The increases in SOD activity is
marked by the reduction of Ce4+ to Ce3+. The same trend can be observed in the % of antioxidant
capacity which initially increases and then decreases after day 34. The catalase mimetic activity
which is inversely proportional to the SOD mimetic activity in this case decreases due to decrease
in concentration of Ce4+ and then increases after day 14.
The expedited time based study of photo-reduction of CNPs with time using a high
powered xenon lamp has been performed to observe the change in properties of Dex-CNPs due
to change in intensity of the light. The UV-Vis Spec analysis revealed that the concentration of
Ce4+ is decreases indicating its reduction to form Ce3+ and this change is clearly exponential given
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by the equation a+

be-cx (where a, b, and c are fitting parameters), which is the trend achieved

in the reduction of Ce4+ in case of exposure to normal room light. The slope of the initial reduction
given by the parameter c is higher in case of exposure to high intensity visible light compared to
that of exposure to room light. This similarity is further confirmed by the change in band gap
which decreases representing a red shift. The SOD mimetic activity of Dex-CNPs follows similar
trend to that obtained in case of exposure to normal room light.
In this study we have demonstrated that the Dex-CNPs are significantly sensitive to light
and its properties such as electronic, surface chemistry, dispersion stability, pH, cytotoxicity and
bioactivity changes with the photo-reduction of CNPs due to exposure to light. This poses a
storage and handling concern for Dex-CNPs to preserve its properties. This study also shows how
light can change the surface chemistry of the nanoparticle, in turn changing its microenvironment,
thereby changing its interaction with other substrate and entities.
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